ACRO Executive Director Discusses Data Privacy and CER in Health Affairs Article

WASHINGTON--(BUSINESS WIRE)-- Doug Peddicord, Ph.D., Executive Director of the Association of Clinical Research Organizations, is the lead author of “A Proposal To Protect Privacy Of Health Information While Accelerating Comparative Effectiveness Research” appearing in the November 2010 issue of Health Affairs.

The article proposes a policy framework that balances the needs of researchers to access data with the desire to maintain the privacy of sensitive individual health information. In general, the article proposes encouraging the use of health data in comparative effectiveness research by limiting Institutional Review Board involvement in privacy matters and ensuring that individual consent is not required. In exchange, researchers would fall under a “safe harbor” provided that they maintained strict data security controls, standards, and practices promulgated by the Secretary of Health and Human Services and ensured compliance though an annual third-party audit of data security procedures.

“More research today, including CER and drug safety surveillance, is driven by accessing large databases of health information,” said Dr. Peddicord. “The policy framework we discuss in this article would ensure that researchers have access to the information they need to support our health policy objectives while providing a level of comfort around privacy concerns, which we all share.”

Co-authors of the article included: Ann B. Waldo, Senior Counsel to the Genetic Alliance; Marc Boutin, Executive Vice President and COO of the National Health Council; Tina Grande, Senior Vice President for policy at the Healthcare Leadership Council; and Luis Gutierrez, Jr., formerly of Covance.

You may become a fan of ACRO on Facebook and follow us on Twitter @ACROhealth.

About ACRO

The Association of Clinical Research Organizations (ACRO) represents companies whose focus is clinical research. The association provides an active voice for the global CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 70,000 professionals worldwide and annually conduct more than 9,000 clinical trials involving nearly two million participants in 115 countries. For more information, please visit www.acrohealth.org.



CONTACT:

Association of Clinical Research Organizations (ACRO)
John Lewis, 202-464-2310
[email protected]

KEYWORDS:   United States  North America  District of Columbia

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Public Policy/Government  Healthcare Reform  Pharmaceutical  Research  FDA  Science

MEDIA:

Logo
 Logo

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.